Implications of the AHRQ evidence report on acute otitis media

Citation
Rm. Rosenfeld et al., Implications of the AHRQ evidence report on acute otitis media, OTO H N SUR, 125(5), 2001, pp. 440-448
Citations number
26
Categorie Soggetti
Otolaryngology
Journal title
OTOLARYNGOLOGY-HEAD AND NECK SURGERY
ISSN journal
01945998 → ACNP
Volume
125
Issue
5
Year of publication
2001
Pages
440 - 448
Database
ISI
SICI code
0194-5998(200111)125:5<440:IOTAER>2.0.ZU;2-F
Abstract
OBJECTIVE. To familiarize otolaryngologists with the Agency for Healthcare Research and Quality (AHRQ) Evidence Report on Acute Otitis Media (AOM) tha t reviews the natural history and role of antibiotics in management. The re port, by the Southern California Evidence-Based Practice Center (SC-EPC), i s the most recent of 15 literature syntheses published by the AHRQ. DATA SOURCES: MEDLINE (1966 to present), Cochrane Library, EMBASE, BIOSIS, HealthSTAR, and other computerized databases; manual reference search of pr oceedings, articles, reports, and guidelines. STUDY SELECTION: Randomized trials and cohort studies relevant to the natur al history of AOM and the efficacy of antimicrobial therapy. AOM was define d by the 11-member technical expert panel (including 2 authors, RMR and MLC ) as middle-ear effusion with the rapid onset of signs or symptoms of middl e ear inflammation. DATA EXTRACTION: Two physician reviewers at the Southern California. Eviden ce-Based Practice Center independently rated the articles and extracted dat a. DATA SYNTHESIS: Children receiving placebo or no antimicrobial had a poo led clinical success rate of 81% at 1 to 7 days (95% Cl, 72% to 90%), with no increase in suppurative complications when followed closely. Amoxicillin or ampicillin increased the absolute success rate by 12.3% (95% Cl, 2.8% t o 21.8%) in 5 studies pooled using random effects meta-analysis. The antimi crobial benefit was robust to sensitivity analysis. In contrast, success ra tes were not influenced by the choice or duration of therapy. CONCLUSIONS: The AHRQ report emphasizes middle-ear effusion as a preeminent criteria for AOM diagnosis and provides extensive evidence tables on natur al history and antimicrobial impact. About 8 children must receive antibiot ics to avoid I clinical failure, but children younger than age 2 years or w ith severe symptoms may benefit more. The report is a starting point for or ganizations seeking to develop AOM guidelines, performance measures, and ot her quality improvement tools.